Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 |
| | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Elimination | | 1,839.7 | 1,765.9 | 1,872.9 | | | | |
| Security Division | | | | | 747.6 | 690.0 | 555.2 | 411.2 |
| Optoelectronics and Manufacturing Division | | 366.7 | 349.9 | 283.8 | 288.6 | 254.5 | 236.1 | 247.5 |
| Healthcare Division | | 205.7 | 212.3 | 185.3 | 188.5 | 189.4 | 200.0 | 211.5 |
| Total revenues [+] | 1,278.4 | 1,183.2 | 1,146.9 | 1,166.0 | 1,182.1 | 1,089.3 | 961.0 | 829.7 |
| Products | 958.8 | | | | | | | 579.3 |
| Services | 319.6 | | | | | | | 250.3 |
| Revenue growth [+] | 8.0% | 3.2% | -1.6% | -1.4% | 8.5% | 13.4% | 15.8% | -13.4% |
| Elimination | | 4.2% | -5.7% | | | | | |
| Security Division | | | | | 8.3% | 24.3% | 35.0% | -14.5% |
| Optoelectronics and Manufacturing Division | | 4.8% | 23.3% | -1.7% | 13.4% | 7.8% | -4.6% | -7.6% |
| Healthcare Division | | -3.1% | 14.6% | -1.7% | -0.5% | -5.3% | -5.4% | -17.3% |
| Cost of goods sold [+] | 847.9 | 758.8 | 727.0 | 745.4 | 751.5 | 697.6 | 637.5 | 552.8 |
| Cost of product sales | 676.8 | | | | | | | 407.9 |
| Cost of services | 171.1 | | | | | | | 144.9 |
| Gross profit | 430.5 | 424.4 | 419.9 | 420.6 | 430.6 | 391.7 | 323.5 | 276.9 |
| Gross margin | 33.7% | 35.9% | 36.6% | 36.1% | 36.4% | 36.0% | 33.7% | 33.4% |
| Selling, general and administrative | 228.3 | 235.6 | 240.7 | 252.0 | 262.5 | 239.6 | 192.6 | 166.7 |
| Research and development | 59.4 | 59.6 | 53.7 | 57.3 | 56.5 | 61.2 | 51.0 | 49.8 |
| Other operating expenses | | | | | -3.8 | -62.1 | -67.2 | -12.5 |
| EBITDA [+] | | 168.0 | 169.3 | 161.1 | 171.7 | 222.8 | 215.4 | 130.8 |
| EBITDA growth | -15.0% | -0.8% | 5.1% | -6.1% | -22.9% | 3.4% | 64.6% | -24.5% |
| EBITDA margin | 11.2% | 14.2% | 14.8% | 13.8% | 14.5% | 20.4% | 22.4% | 15.8% |
| Depreciation | | 21.0 | 22.4 | 29.1 | 34.8 | 50.3 | 55.9 | 52.2 |
| EBITA | 142.8 | 147.0 | 147.0 | 132.1 | 136.8 | 172.5 | 159.5 | 78.6 |
| EBITA margin | 11.2% | 12.4% | 12.8% | 11.3% | 11.6% | 15.8% | 16.6% | 9.5% |
| Amortization of intangibles | | 17.7 | 21.5 | 20.7 | 21.4 | 19.5 | 12.3 | 5.7 |
| EBIT [+] | 142.8 | 129.3 | 125.5 | 111.4 | 115.4 | 153.0 | 147.2 | 72.9 |
| EBIT growth | 10.5% | 3.0% | 12.7% | -3.5% | -24.6% | 4.0% | 101.8% | -36.2% |
| EBIT margin | 11.2% | 10.9% | 10.9% | 9.6% | 9.8% | 14.0% | 15.3% | 8.8% |
| Non-recurring items [+] | 7.6 | 7.5 | 10.1 | 6.5 | 7.7 | 97.1 | 113.9 | 34.5 |
| Asset impairment | | | | | 3.8 | 35.0 | 46.7 | 22.0 |
| Interest expense | | | | | | | 9.6 | 2.9 |
| Interest expense | | | | | | | 9.6 | 2.9 |
| Other income (expense), net | -20.0 | 18.4 | -16.7 | -18.8 | -21.6 | -19.1 | 2.1 | 0.0 |
| Pre-tax income | 115.2 | 140.2 | 98.6 | 86.1 | 86.2 | 36.9 | 25.8 | 35.5 |
| Income taxes | 23.5 | 24.8 | 24.6 | 10.9 | 21.4 | 66.0 | 4.7 | 9.3 |
| Tax rate | 20.4% | 17.7% | 24.9% | 12.6% | 24.8% | 179.0% | 18.2% | 26.3% |
| Net income | 91.8 | 115.3 | 74.0 | 75.3 | 64.8 | -29.1 | 21.1 | 26.2 |
| Net margin | 7.2% | 9.7% | 6.5% | 6.5% | 5.5% | -2.7% | 2.2% | 3.2% |
| |
| Basic EPS [+] | $5.34 | $6.57 | $4.12 | $4.14 | $3.58 | ($1.57) | $1.12 | $1.35 |
| Growth | -18.8% | 59.5% | -0.4% | 15.5% | -328.5% | -240.4% | -17.2% | -59.1% |
| Diluted EPS [+] | $5.34 | $6.45 | $4.03 | $4.05 | $3.46 | ($1.57) | $1.07 | $1.30 |
| Growth | -17.3% | 60.3% | -0.5% | 16.9% | -320.9% | -246.4% | -17.8% | -59.0% |
| |
| Shares outstanding (basic) [+] | 17.2 | 17.6 | 18.0 | 18.2 | 18.1 | 18.6 | 18.9 | 19.4 |
| Growth | -2.1% | -2.3% | -1.2% | 0.5% | -2.7% | -1.6% | -2.7% | -1.9% |
| Shares outstanding (diluted) [+] | 17.2 | 17.9 | 18.4 | 18.6 | 18.7 | 18.6 | 19.7 | 20.1 |
| Growth | -3.8% | -2.8% | -1.1% | -0.6% | 0.7% | -5.6% | -1.9% | -2.2% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|